Use of IL-6-elafin genetically modified regulatory macrophages as an immunotherapy against acute Pseudomonas aeruginosa infection in the lung

Autor: Kheir, S., Villeret, B., Garcia-Verdugo, I., Sallenave, J.M.
Zdroj: In Revue des Maladies Respiratoires June 2021 38(6):583-583
Databáze: ScienceDirect